Article
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
PloS one - 1 Jan 2014
Hwang Kwan-Ki, Trama Ashley M, Kozink Daniel M, Chen Xi, Wiehe Kevin, Cooper Abby J, Xia Shi-Mao, Wang Minyue, Marshall Dawn J, Whitesides John, Alam Munir, Tomaras Georgia D, Allen Steven L, Rai Kanti R, McKeating Jane, Catera Rosa, Yan Xiao-Jie, Chu Charles C, Kelsoe Garnett, Liao Hua-Xin, Chiorazzi Nicholas, Haynes Barton F
Abstract excerpt
B-cell chronic lymphocytic leukemia (B-CLL) patients expressing unmutated immunoglobulin heavy variable regions (IGHVs) use the IGHV1-69 B cell receptor (BCR) in 25% of cases. Since HIV-1 envelope gp41 antibodies also frequently use IGHV1-69 gene segments, we hypothesized that IGHV1-69 B-CLL precursors may contribute to the gp41 B cell response during HIV-1 infection. To test this hypothesis, we rescued 5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
